Byotrol Plc
("Byotrol" or the "Group")
Exercise of Options and Total Voting Rights
Byotrol plc (AIM: BYOT), the anti-microbial technology company, announces that it has allotted a total of 6,765,000 new ordinary shares of 0.25 pence each in the capital of the Company ("Ordinary Shares") following the exercise of 6,540,000 options by certain Directors and 225,000 by certain employees below Board level. Of these, 5,965,000 options were reaching maturity and were due to expire in the current calendar year.
All 6,540,000 of the Ordinary Shares issued to the Directors below were subsequently sold at a price of 6.92p. The details of those exercised and sold by such Directors is below:
| Director | Total number of share options exercised | Number of Ordinary Shares sold | Resultant Shareholding | Percentage of the Company's issued share capital held | Remaining number of options held |
| David Traynor | 2,360,000 | 2,360,000 | 9,691,142 | 2.14 | 2,710,000 |
| Nic Hellyer | 800,000 | 800,000 | 629,870 | 0.14 | 1,200,000 |
| John Langlands | 2,700,000 | 2,700,000 | 9,000,000 | 1.99 | Nil |
| Dr Trevor Francis | 680,000 | 680,000 | 4,470,214 | 0.99 | 4,730,000 |
| | | | | | |
Application has been made for the 6,765,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 5 May 2021.
After Admission, the total number of Ordinary Shares in issue will be 453,295,405 and the total number of voting rights will therefore be 453,295,405. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
For further information contact:
| Byotrol Plc | |
| David Traynor, Chief Executive | +44 (0)1925 742 000 |
| Nic Hellyer, Chief Financial Officer | |
| | |
| finnCap Limited (Nominated Adviser and Broker) | +44 (0)20 7220 0500 |
| Geoff Nash/Kate Bannatyne - Corporate Finance | |
| Richard Chambers - ECM | |
| | |
| Flagstaff Strategic and Investor Communications | +44 (0)20 7129 1474 |
| Tim Thompson/Andrea Seymour/Fergus Mellon
|
|
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||||||
| a) | Name | David Traynor | ||||||||||||
| 2. | Reason for the Notification. | |||||||||||||
| a) | Position/status | CEO | ||||||||||||
| b) | Initial notification/Amendment |
| ||||||||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||||
| a) | Name | Byotrol plc | ||||||||||||
| b) | LEI | 213800AJMTSTIPA59A34 | ||||||||||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||||||
| a) | Description of the Financial instrument, type of instrument |
| ||||||||||||
| Identification code | GB00B0999995 | |||||||||||||
| b) | Nature of the transaction |
| ||||||||||||
| c) | Price(s) and volume(s) |
| ||||||||||||
| d) | Aggregated information: · Aggregated volume · Price |
As above | ||||||||||||
| e) | Date of the transaction | 27 April 2021 | ||||||||||||
| f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) | ||||||||||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
| a) | Name | Nic Hellyer | ||||||||
| 2. | Reason for the Notification. | |||||||||
| a) | Position/status | CFO | ||||||||
| b) | Initial notification/Amendment |
| ||||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
| a) | Name | Byotrol plc | ||||||||
| b) | LEI | 213800AJMTSTIPA59A34 | ||||||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
| a) | Description of the Financial instrument, type of instrument |
| ||||||||
| Identification code | GB00B0999995 | |||||||||
| b) | Nature of the transaction |
| ||||||||
| c) | Price(s) and volume(s) |
| ||||||||
| d) | Aggregated information: · Aggregated volume · Price |
As above | ||||||||
| e) | Date of the transaction | 27 April 2021 | ||||||||
| f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) | ||||||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
| a) | Name | John Langlands | ||||||||
| 2. | Reason for the Notification. | |||||||||
| a) | Position/status | Non-Executive Chairman | ||||||||
| b) | Initial notification/Amendment |
| ||||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
| a) | Name | Byotrol plc | ||||||||
| b) | LEI | 213800AJMTSTIPA59A34 | ||||||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
| a) | Description of the Financial instrument, type of instrument |
| ||||||||
| Identification code | GB00B0999995 | |||||||||
| b) | Nature of the transaction |
| ||||||||
| c) | Price(s) and volume(s) |
| ||||||||
| d) | Aggregated information: · Aggregated volume · Price |
As above | ||||||||
| e) | Date of the transaction | 27 April 2021 | ||||||||
| f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) | ||||||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||||||||||
| a) | Name | Dr Trevor Francis | ||||||||||||
| 2. | Reason for the Notification. | |||||||||||||
| a) | Position/status | Chief Technology Officer | ||||||||||||
| b) | Initial notification/Amendment |
| ||||||||||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||||
| a) | Name | Byotrol plc | ||||||||||||
| b) | LEI | 213800AJMTSTIPA59A34 | ||||||||||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||||||
| a) | Description of the Financial instrument, type of instrument |
| ||||||||||||
| Identification code | GB00B0999995 | |||||||||||||
| b) | Nature of the transaction |
| ||||||||||||
| c) | Price(s) and volume(s) |
| ||||||||||||
| d) | Aggregated information: · Aggregated volume · Price |
As above | ||||||||||||
| e) | Date of the transaction | 27 April 2021 | ||||||||||||
| f) | Place of the transaction | London Stock Exchange, AIM Market (XLON) | ||||||||||||
Notes to editors
Byotrol plc (BYOT.L), quoted on AIM, is a specialist infection prevention and control company, operating globally in the Healthcare, Industrial, Food and Consumer sectors, providing low toxicity products with a broad-based and targeted efficacy across all microbial classes; bacteria, viruses (including coronavirus), fungi, moulds, mycobacteria and algae.
Byotrol's products can be used stand-alone or as ingredients within existing products, where they can significantly improve their performance, especially in personal hygiene, domestic and industrial disinfection, odour control, food production and food management.
Byotrol develops and commercialises technologies that create easier, safer and cleaner lives for everyone.
For more information, please go to byotrol.co.uk
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
